Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caucaseco Biological Research Center, officially known as Centro de Investigación Científica Caucaseco, is a prominent Colombian research institution specializing in tropical diseases, particularly malaria. Based in Cali, the center integrates basic laboratory research, epidemiological field studies, and clinical trials to develop novel interventions for malaria prevention and control. The organization is internationally recognized for its expertise in Plasmodium vivax, leading the development of several vaccine candidates including transmission-blocking and circumsporozoite-based formulations. Through strategic partnerships with the NIH, the Bill & Melinda Gates Foundation, and various global universities, Caucaseco plays a pivotal role in the global effort to eliminate malaria in endemic regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caucaseco Biological Research Center.